Status:

WITHDRAWN

nHFOV Versus Invasive Conventional Ventilation for Preterm Neonates With Respiratory Distress Syndrome

Lead Sponsor:

Indus Hospital and Health Network

Conditions:

Respiratory Distress Syndrome in Premature Infant

Eligibility:

All Genders

1-6 years

Phase:

NA

Brief Summary

Preterm neonates usually develop respiratory distress syndrome (RDS) for which they need respiratory support, which may be invasive and non-invasive depend on the availability and individual need. Non...

Detailed Description

Respiratory distress is a common morbidity in preterm neonates that requires respiratory support and surfactant replacement, if not adequately and timely managed may cause multi-organ dysfunction. Res...

Eligibility Criteria

Inclusion

  • Inborn Preterm Neonates 26-34 weeks gestation admitted to NICU with diagnosis of RDS
  • Babies who were initially started on High Flow Oxygen Therapy/nCPAP but unable to maintain saturation \> 90% on fio2 of 40% in 1st 6 hours of life.
  • Capillary PCO2 of \> 70 or arterial PCO2 \> 65 on two repeated sampling within 4 hours
  • Neonates whose parents consented to participate.

Exclusion

  • All preterm babies who are below \< 26 weeks above the 34 weeks of gestation
  • Preterm neonates (26-34 weeks) with diagnosis of RDS requiring endotracheal intubation within Labor room/Operation Theater or within 1st hour of life for respiratory support.
  • Preterm Neonates with the gestational age of 26-34 weeks, diagnosed as congenital pneumonia or sepsis.
  • Patient with poor respiratory drive due to any reason neurological or central causes
  • Diaphragmatic hernia or any other thoracic anomaly
  • Pleural effusion unilateral or bilateral
  • Congenital cystic pulmonary malformation.
  • Neonates with underlying cyanotic heart disease.
  • Neonates with acynotic heart disease causing pulmonary edema
  • Neonates with cleft lip and cleft palate or any other surgical condition.

Key Trial Info

Start Date :

June 30 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 30 2023

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04914715

Start Date

June 30 2021

End Date

December 30 2023

Last Update

March 12 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Indus Hospital and Health Network

Karachi, Sindh, Pakistan, 75190